Dog /
FDA CVM · 2025 release 168 reports on file

Foxhound (unspecified) - FDA Adverse Event Profile

Adverse-event records for Foxhound (unspecified) (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 18 13.5 9 4.5 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Foxhound (unspecified) drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Foxhound (unspecified)'s FDA record: #195 most-reported dog breed, 168 total reports, 4.8% death-coded (8 reports).

#195
most-reported dog breed
4.8%
death-coded report share
36
Lack of efficacy (endoparasite) - hookworm - top reaction
5.3 yr
average age at report

Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.

Total Reports

168

FDA CVM filings

Deaths Reported

8

of 168 reports

Death Rate

4.8%

death-coded share

Avg Age at Report

5.3 yr

24.9 kg avg weight

Death-Coded Outcome Share

Foxhound (unspecified) death-coded reports 4.8%
Cross-breed median

4.8% of 168 foxhound (unspecified) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 24.9 kg (54.9 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - hookworm 36
Vomiting 29
Lethargy (see also Central nervous system depression in 'Neurological') 14
Lack of efficacy (endoparasite) - heartworm 14
Diarrhoea 13
INEFFECTIVE, HOOKS 10
Lack of efficacy (endoparasite) - whipworm 7
Depression 6

Most Referenced Drugs

Milbemycin Oxime + Spinosad 23
Pyrantel Pamoate;Sarolaner 23
Milbemycin Oxime + Praziquantel 22
Ivermectin + Pyrantel As Pamoate Salt 15
Moxidectin 12
Melarsomine Dihydrochloride 8
Ivermectin 8
Imidacloprid + Moxidectin 8

Outcome Breakdown

Outcome Unknown
59 (39.3%)
Ongoing
50 (33.3%)
Recovered/Normal
32 (21.3%)
Died
4 (2.7%)
Euthanized
4 (2.7%)
Recovered with Sequela
1 (0.7%)

Gender Distribution

Female 87 (51.8%)
Male 72 (42.9%)
Unknown 8 (4.8%)
Mixed 1 (0.6%)

Reports by Year

Year Reports Trend
2010 10
2011 5
2012 7
2013 10
2014 6
2015 4
2016 17
2017 11
2018 4
2019 7
2020 10
2021 17
2022 13
2023 16
2024 18
2025 13

Foxhound (unspecified) Pet Health Insights

Foxhound (unspecified) accounts for 168 FDA adverse event reports, ranking #195 by volume among dog breeds, with 8 reports (4.8%) coded as a death outcome. Mean age at report: 5.3 years, average weight 24.9 kg (54.9 lbs).

Top reported signs: Lack of efficacy (endoparasite) - hookworm (36), Vomiting (29), Lethargy (see also Central nervous system depression in 'Neurological') (14). Most-referenced drug: Milbemycin Oxime + Spinosad (23 reports), followed by Pyrantel Pamoate;Sarolaner (23) and Milbemycin Oxime + Praziquantel (22).

Outcome coding on 150 status-recorded reports is dominated by Outcome Unknown (39.3%). Annual submissions ranged 2,010-2,025 across 16 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Foxhound (unspecified)?
There are 168 adverse event reports involving Foxhound (unspecified) in the FDA database, with 8 reports involving death (4.8% death rate). Foxhound (unspecified) ranks #195 by report volume.
What are the most common adverse reactions reported for Foxhound (unspecified)?
The most commonly reported adverse reactions for Foxhound (unspecified) are Lack of efficacy (endoparasite) - hookworm (36 reports), Vomiting (29 reports), Lethargy (see also Central nervous system depression in 'Neurological') (14 reports), Lack of efficacy (endoparasite) - heartworm (14 reports), Diarrhoea (13 reports).
What drugs are most frequently associated with Foxhound (unspecified) adverse events?
The drugs most frequently referenced in Foxhound (unspecified) adverse event reports are Milbemycin Oxime + Spinosad (23 reports), Pyrantel Pamoate;Sarolaner (23 reports), Milbemycin Oxime + Praziquantel (22 reports), Ivermectin + Pyrantel As Pamoate Salt (15 reports), Moxidectin (12 reports).
What is the average age of Foxhound (unspecified) in adverse event reports?
The average age of Foxhound (unspecified) at the time of adverse event reports is 5.3 years, with an average weight of 24.9 kg (54.9 lbs).
Does a high number of adverse event reports mean Foxhound (unspecified) is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Foxhound (unspecified) safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.